{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:30:18Z","timestamp":1782909018655,"version":"3.54.5"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:p>\n                    Hormone receptor (HR) status is a critical biomarker used to formulate treatment programs and prognosis in breast cancer. Traditional immunohistochemistry relies on invasive tissue samples and may not accurately reflect tumor heterogeneity. Radiomics is a noninvasive technique that involves extracting quantitative imaging characteristics from molecular profiles. The purpose of this study is to develop a combined ultrasound (US)-radiomics model to predict HR status in invasive breast cancer. A retrospective cohort of 186 patients with invasive breast carcinoma, which had been pathologically confirmed, was used in this study, comprising 150 cases (HR-positive (ER\n                    <jats:sup>+<\/jats:sup>\n                    \/PR\n                    <jats:sup>\u2212<\/jats:sup>\n                    , HER-2\u2212)) and 36 cases (HR-negative (ER\n                    <jats:sup>\u2212<\/jats:sup>\n                    \/PR\n                    <jats:sup>\u2212<\/jats:sup>\n                    , HER-2\u2212)). B-mode US images of the tumor regions were manually segmented, and 463 radiomic features were obtained.\n                    <jats:italic toggle=\"yes\">T<\/jats:italic>\n                    tests, ANOVA, and recursive methods were applied to create a list of features. A support vector machine with a radial basis function kernel was trained using leave-one-out cross-validation. To measure model performance, accuracy, sensitivity, specificity, area under the curve (AUC), and 95% confidence intervals (CIs) were used. The hybrid model had an AUC of 0.728 (95% CI: 0.701\u20130.755) and an accuracy of 67.9. The model with the highest AUC (0.753, 95% CI: 0.7240.782) was the internal echo-based model. HR-negative tumors were larger, had higher marker of proliferation (Ki-67) indices, and showed greater textural heterogeneity than HR-positive lesions (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). US-radiomics combined modeling is a promising, cost-effective, and radiation-free approach to noninvasive imaging that can predict HR status in breast cancer. US biomarkers can be quantitative, providing insights into tumor microstructure to personalize diagnostic and therapeutic approaches.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047576","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:01:42Z","timestamp":1771628502000},"page":"e47576","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Predicting hormone receptor status in tumors: An innovative approach using breast ultrasound-radiomics combined model"],"prefix":"10.1097","volume":"105","author":[{"given":"Xue","family":"Yin","sequence":"first","affiliation":[{"name":"Special Inspection Department, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5643-6112","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Special Inspection Department, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxian","family":"Zhao","sequence":"additional","affiliation":[{"name":"Special Inspection Department, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Special Inspection Department, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Sang","sequence":"additional","affiliation":[{"name":"Special Inspection Department, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjie","family":"Shao","sequence":"additional","affiliation":[{"name":"Special Inspection Department, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1200\/JCO.2009.25.6529","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.","volume":"28","author":"Hammond","year":"2010","journal-title":"J Clin Oncol"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrc2571","article-title":"Do \u201cbasal-like\u201d breast cancers really exist?","volume":"9","author":"Gusterson","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"e000842","DOI":"10.1136\/esmoopen-2020-000842","article-title":"Endocrine therapy-based treatments in hormone receptor-positive\/HER2-negative advanced breast cancer: a network meta-analysis.","volume":"5","author":"Park","year":"2020","journal-title":"ESMO Open"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/S0140-6736(11)61539-0","article-title":"Gene expression profiling in breast cancer: classification, prognostication, and prediction.","volume":"378","author":"Reis-Filho","year":"2011","journal-title":"Lancet"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrclinonc.2015.123","article-title":"Precision medicine for metastatic breast cancer \u2013 limitations and solutions.","volume":"12","author":"Arnedos","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiol.2015151169","article-title":"Radiomics: images are more than pictures, they are data.","volume":"278","author":"Gillies","year":"2016","journal-title":"Radiology"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1148\/radiol.2018172171","article-title":"Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment.","volume":"287","author":"Pinker","year":"2018","journal-title":"Radiology"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1001\/jama.299.18.2151","article-title":"Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer.","volume":"299","author":"Berg","year":"2008","journal-title":"JAMA"},{"key":"R12-20260523","first-page":"6569","article-title":"Radiomic signatures from contrast-enhanced breast MRI predict immune phenotype in breast cancer.","volume":"30","author":"Leithner","year":"2020","journal-title":"Eur Radiol"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis.","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","article-title":"A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.","volume":"19","author":"Sun","year":"2018","journal-title":"Lancet Oncol"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"837257","DOI":"10.3389\/fonc.2022.837257","article-title":"Preoperative prediction of breast cancer molecular subtypes with radiomics: a systematic review and meta-analysis.","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"R16-20260523","first-page":"20201074","article-title":"Radiomics features on ultrasound imaging for prediction of disease-free survival in triple-negative breast cancer: a multi-institutional study.","volume":"94","author":"Wang","year":"2021","journal-title":"Br J Radiol"},{"key":"R17-20260523","first-page":"1090617","article-title":"An ultrasound-based radiomics model to predict molecular subtypes of breast cancer.","volume":"13","author":"Gao","year":"2023","journal-title":"Front Oncol"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"104117","DOI":"10.1016\/j.medengphy.2024.104117","article-title":"Benign and malignant classification of breast tumor ultrasound images using conventional radiomics and transfer learning features: a multicenter retrospective study.","volume":"125","author":"Tian","year":"2024","journal-title":"Med Eng Phys"},{"key":"R19-20260523","first-page":"640090","article-title":"Prediction of Ki-67 expression level using ultrasound image features and clinicopathological parameters.","volume":"11","author":"Chang","year":"2021","journal-title":"Front Oncol"},{"key":"R20-20260523","first-page":"906420","article-title":"A radiomics model for predicting the outcome of lumina: A molecular subtype of breast cancer based on dynamic contrast-enhanced MRI.","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"R21-20260523","first-page":"708220","article-title":"A CT-based radiomics nomogram for differentiation of benign and malignant breast lesions.","volume":"11","author":"Nie","year":"2021","journal-title":"Front Oncol"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3389\/fonc.2020.01410","article-title":"Radiomics nomogram based on MRI for predicting neoadjuvant chemotherapy response in breast cancer patients.","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Oncol"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"7733583","DOI":"10.1155\/2022\/7733583","article-title":"Discrimination of breast cancer based on ultrasound images and convolutional neural networks.","volume":"2022","author":"Du","year":"2022","journal-title":"J Oncol"},{"key":"R24-20260523","first-page":"3240","article-title":"Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer.","volume":"26","author":"Yoon","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"e232554","DOI":"10.1148\/radiol.232554","article-title":"Combining radiomics and autoencoders to distinguish benign and malignant breast tumors on US images.","volume":"312","author":"Magnuska","year":"2024","journal-title":"Radiology"},{"key":"R26-20260523","first-page":"336","article-title":"Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters.","volume":"21","author":"Ma","year":"2021","journal-title":"BMC Cancer"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1148\/radiol.2016152110","article-title":"MR imaging radiomics signatures for predicting breast cancer recurrence, as reported in research versions of the MammaPrint, Oncotype DX, and PAM50 gene assays.","volume":"281","author":"Li","year":"2016","journal-title":"Radiology"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/radiol.2016160261","article-title":"Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes.","volume":"282","author":"Kim","year":"2017","journal-title":"Radiology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T23:01:57Z","timestamp":1779577317000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047576","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"2025-08-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}